603590 康辰药业
已收盘 07-18 15:00:00
资讯
新帖
简况
7月18日康辰药业(603590)龙虎榜数据:游资上海溧阳路上榜
证券之星 · 09:15
7月18日康辰药业(603590)龙虎榜数据:游资上海溧阳路上榜
康辰药业涨9.46%,太平洋二个月前给出“买入”评级
证券之星 · 08:18
康辰药业涨9.46%,太平洋二个月前给出“买入”评级
创新药概念股拉升 欧林生物、金城医药涨超10%
E公司 · 05:57
创新药概念股拉升 欧林生物、金城医药涨超10%
异动快报:康辰药业(603590)7月18日13点51分触及涨停板
证券之星 · 05:55
异动快报:康辰药业(603590)7月18日13点51分触及涨停板
康辰药业跌5.04% 资金博弈与估值过高引发抛压
智选洞察 · 01:49
康辰药业跌5.04% 资金博弈与估值过高引发抛压
康辰药业下跌5.19% 创新药预期升温引发估值回调
智选洞察 · 07-16 01:31
康辰药业下跌5.19% 创新药预期升温引发估值回调
关于“光大嘉宝”、“中银证券”等证券交易异常波动的风险提示
国金证券第5小时 · 07-15
关于“光大嘉宝”、“中银证券”等证券交易异常波动的风险提示
康辰药业涨5.07%创近5年新高 资金博弈与政策预期共振推升股价
智选洞察 · 07-15
康辰药业涨5.07%创近5年新高 资金博弈与政策预期共振推升股价
医药主题基金首批二季报出炉!这只产品规模环比增30倍
北京商报官方账号 · 07-14
医药主题基金首批二季报出炉!这只产品规模环比增30倍
康辰药业涨5% 券商看好
智选洞察 · 07-14
康辰药业涨5% 券商看好
每周股票复盘:康辰药业(603590)股票连续三日涨幅偏离值累计超20%
证券之星 · 07-12
每周股票复盘:康辰药业(603590)股票连续三日涨幅偏离值累计超20%
康辰药业最新公告:全资子公司康辰药业(香港)有限公司持有Nuance Biotech 4.96%股权
证券之星 · 07-11
康辰药业最新公告:全资子公司康辰药业(香港)有限公司持有Nuance Biotech 4.96%股权
7月11日康辰药业(603590)龙虎榜数据:机构净买入3167.54万元(3日)
证券之星 · 07-11
7月11日康辰药业(603590)龙虎榜数据:机构净买入3167.54万元(3日)
7月10日康辰药业(603590)涨停分析:创新药突破、营销转型、高分红驱动
证券之星 · 07-10
7月10日康辰药业(603590)涨停分析:创新药突破、营销转型、高分红驱动
【创新药概念股反复活跃,塞力医疗、康辰药业触及涨停】创新药概念股反复活跃,塞力医疗、康辰药业触及涨停,海思科涨超7%,先达股份、华纳药厂、微芯生物纷纷上涨。
金融界 · 07-10
【创新药概念股反复活跃,塞力医疗、康辰药业触及涨停】创新药概念股反复活跃,塞力医疗、康辰药业触及涨停,海思科涨超7%,先达股份、华纳药厂、微芯生物纷纷上涨。
异动快报:康辰药业(603590)7月9日13点13分触及涨停板
证券之星 · 07-09
异动快报:康辰药业(603590)7月9日13点13分触及涨停板
康辰药业涨5.33% 创新药政策落地引发资金博弈
智选洞察 · 07-09
康辰药业涨5.33% 创新药政策落地引发资金博弈
康辰药业涨5.8% 券商看好
智选洞察 · 07-07
康辰药业涨5.8% 券商看好
每周股票复盘:康辰药业(603590)KC1086获临床试验许可,赎回2000万现金管理产品
证券之星 · 07-05
每周股票复盘:康辰药业(603590)KC1086获临床试验许可,赎回2000万现金管理产品
康辰药业涨5.13% 创新药管线价值重估预期升温
智选洞察 · 07-03
康辰药业涨5.13% 创新药管线价值重估预期升温
加载更多
公司概况
公司名称:
北京康辰药业股份有限公司
所属行业:
医药制造业
上市日期:
2018-08-27
主营业务:
北京康辰药业股份有限公司的主营业务是医药制造业,从事化学药品制剂制造。公司的主要产品是注射用尖吻蝮蛇血凝酶、鲑降钙素注射液、鲑降钙素鼻用喷雾剂。公司被授予“中国医药创新企业100强”、“中国化药企业TOP100排行榜”、“北京制造业企业百强”、“北京高精尖企业百强”、“北京专精特新企业百强”、“北京市就业创业工作先进集体”、“北京市密云区统计诚信示范企业”,以及“2024年度中药创新十大贡献企业金手杖奖”等荣誉资质,企业实力再获认可。
发行价格:
24.34
{"stockData":{"symbol":"603590","market":"SH","secType":"STK","nameCN":"康辰药业","latestPrice":54.75,"timestamp":1752822000000,"preClose":50.02,"halted":0,"volume":13579107,"delay":0,"changeRate":0.0946,"floatShares":157000000,"shares":159000000,"eps":0.2828,"marketStatus":"已收盘","change":4.73,"latestTime":"07-18 15:00:00","open":49.02,"high":55.02,"low":47.4,"amount":701000000,"amplitude":0.1523,"askPrice":54.75,"askSize":230,"bidPrice":54.72,"bidSize":28,"shortable":0,"etf":0,"ttmEps":0.2828,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753061400000},"marketStatusCode":5,"adr":0,"adjPreClose":50.02,"symbolType":"stock","openAndCloseTimeList":[[1752802200000,1752809400000],[1752814800000,1752822000000]],"highLimit":55.02,"lowLimit":45.02,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":159356477,"isCdr":false,"pbRate":2.77,"roa":"--","peRate":193.599717,"roe":"1.41%","epsLYR":0.27,"committee":-0.507874,"marketValue":8725000000,"turnoverRate":0.0864,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2025-07-21。","floatMarketCap":8609000000},"requestUrl":"/m/hq/s/603590","defaultTab":"news","newsList":[{"id":"2552650804","title":"7月18日康辰药业(603590)龙虎榜数据:游资上海溧阳路上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2552650804","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552650804?lang=zh_cn&edition=full","pubTime":"2025-07-18 17:15","pubTimestamp":1752830111,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2025年7月18日公布的交易公开信息显示,康辰药业因有价格涨跌幅限制的日价格振幅达到15%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年7月18日收盘,康辰药业报收于54.75元,上涨9.46%,换手率8.64%,成交量13.58万手,成交额7.01亿元。从龙虎榜公布的当日买卖数据来看,机构合计净买入3359.91万元。上海溧阳路等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071800027487.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603590"],"gpt_icon":0},{"id":"2552246877","title":"康辰药业涨9.46%,太平洋二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2552246877","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552246877?lang=zh_cn&edition=full","pubTime":"2025-07-18 16:18","pubTimestamp":1752826734,"startTime":"0","endTime":"0","summary":"今日康辰药业(603590)涨9.46%,收盘报54.75元。2025年4月30日,太平洋研究员谭紫媚,张懿发布了对康辰药业的研报《康辰药业:核心产品市场潜力大,多款创新药快速推进》,该研报对康辰药业给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为36.46%。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为长江证券的彭英骐。康辰药业(603590)个股概况:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071800025237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603590","601099"],"gpt_icon":0},{"id":"2552523824","title":"创新药概念股拉升 欧林生物、金城医药涨超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552523824","media":"E公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552523824?lang=zh_cn&edition=full","pubTime":"2025-07-18 13:57","pubTimestamp":1752818241,"startTime":"0","endTime":"0","summary":"人民财讯7月18日电,创新药概念股拉升,欧林生物、金城医药涨超10%,昂利康、康辰药业、汉商集团涨停。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718135721a6b15730&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718135721a6b15730&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688319","BK0239","BK0209","603590","300233","600774","159992","BK0028"],"gpt_icon":0},{"id":"2552045473","title":"异动快报:康辰药业(603590)7月18日13点51分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2552045473","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552045473?lang=zh_cn&edition=full","pubTime":"2025-07-18 13:55","pubTimestamp":1752818119,"startTime":"0","endTime":"0","summary":"证券之星7月18日盘中消息,13点51分康辰药业(603590)触及涨停板。目前价格55.02,上涨10.0%。其所属行业生物制品目前下跌。领涨股为欧林生物。该股为创新药,医药,创投概念热股。7月18日的资金流向数据方面,主力资金净流出742.36万元,占总成交额2.65%,游资资金净流出450.51万元,占总成交额1.61%,散户资金净流入1192.88万元,占总成交额4.26%。近5日资金流向一览见下表:康辰药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071800018008.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603590"],"gpt_icon":0},{"id":"2552453570","title":"康辰药业跌5.04% 资金博弈与估值过高引发抛压","url":"https://stock-news.laohu8.com/highlight/detail?id=2552453570","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552453570?lang=zh_cn&edition=full","pubTime":"2025-07-18 09:49","pubTimestamp":1752803375,"startTime":"0","endTime":"0","summary":"康辰药业股价大幅下跌,最新价47.50元/股,跌幅5.04%。资金博弈与估值切换催生价格波动康辰药业净流入与短期资金面剧烈波动密切相关。截至7月14日,主力资金累计净流入4185.2万元,但7月17日单日净流出3507.2万元,显示机构调仓分歧显著。核心管线验证决定估值重构空间康辰药业长期走势取决于产品结构优化进程。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718094943a4523682&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718094943a4523682&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603590","BK0239"],"gpt_icon":0},{"id":"2551156581","title":"康辰药业下跌5.19% 创新药预期升温引发估值回调","url":"https://stock-news.laohu8.com/highlight/detail?id=2551156581","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551156581?lang=zh_cn&edition=full","pubTime":"2025-07-16 09:31","pubTimestamp":1752629489,"startTime":"0","endTime":"0","summary":"康辰药业股价大幅下跌,最新价47.50元/股,跌幅达5.19%。资金博弈与政策预期共振康辰药业近期净流入与多重因素叠加相关。截至7月14日,主力资金累计净流入4185.2万元,机构调仓动作显著。市场对子公司持有的创新药权益预期升温,默克百亿美元收购Verona Pharma事件引发对相关管线商业化潜力的联想。当前动态市盈率167.99倍显著高于医药生物板块均值,6家券商给予的38.6元目标价中枢已被突破,显示市场预期分化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716093620a44d7529&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716093620a44d7529&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603590","BK0239","159992"],"gpt_icon":0},{"id":"2551169207","title":"关于“光大嘉宝”、“中银证券”等证券交易异常波动的风险提示","url":"https://stock-news.laohu8.com/highlight/detail?id=2551169207","media":"国金证券第5小时","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551169207?lang=zh_cn&edition=full","pubTime":"2025-07-15 17:47","pubTimestamp":1752572835,"startTime":"0","endTime":"0","summary":"尊敬的投资者:“光大嘉宝”(600622)、“中银证券”(601696)、“晨光新材”(605399)、“京运通”(601908)、“绿地控股”(600606)、“联环药业”(600513)、“北方稀土”(600111)、“大智慧”(601519)、“华媒控股”(000607)、“东宏股份”(603856)、“启迪药业”(000590)、“普联软件”(300996)、“宏柏新材”(605366)、“康辰药业”(603590)已触及异常波动情形,请您及时关注上市公司最新公告并注意投资风险。国金证券股份有限公司2025年7月14日","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715185117a44c35eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715185117a44c35eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603856","BK0276","BK0239","600111","605399","BK0273","BK0185","601519","601908","601696","600622","605366","603590","600606","600513"],"gpt_icon":0},{"id":"2551329661","title":"康辰药业涨5.07%创近5年新高 资金博弈与政策预期共振推升股价","url":"https://stock-news.laohu8.com/highlight/detail?id=2551329661","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551329661?lang=zh_cn&edition=full","pubTime":"2025-07-15 09:30","pubTimestamp":1752543051,"startTime":"0","endTime":"0","summary":"康辰药业今日股价大幅上涨,截至09点30分,最新价报50.75元,上涨5.07%,突破50元整数关口并创近5年新高。资金博弈与政策预期共振推升股价康辰药业近期资金流向与多重短期因素叠加相关。动态市盈率从6月底28倍骤升至7月9日129倍,估值快速攀升加剧多空博弈,部分投资者选择在中报披露前兑现收益。当前179.66倍动态市盈率显著高于医药生物板块均值,6家券商给予的38.6元目标价中枢已被突破,显示市场预期分化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715093507a6a9d811&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715093507a6a9d811&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603590","BK0239"],"gpt_icon":0},{"id":"2551188325","title":"医药主题基金首批二季报出炉!这只产品规模环比增30倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2551188325","media":"北京商报官方账号","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551188325?lang=zh_cn&edition=full","pubTime":"2025-07-14 18:40","pubTimestamp":1752489611,"startTime":"0","endTime":"0","summary":"公募基金二季报陆续披露中。就在前几日,长城基金也披露了旗下4只医药主题基金二季报。从规模变动来看,5只医药主题基金环比均有不同幅度的增长,其中长城医药产业精选混合型发起式的最新规模更大涨超30倍。公开资料显示,截至7月14日,已有永赢医药健康股票、长城医药产业精选混合型发起式、长城医药科技六个月持有期混合、长城医疗保健混合、长城大健康混合合计5只医药健康相关主题基金发布2025年二季报。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714184621a6a89973&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714184621a6a89973&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["000121.SH","688068","688382","BK0239","688520","688192","603590","688331"],"gpt_icon":0},{"id":"2551240539","title":"康辰药业涨5% 券商看好","url":"https://stock-news.laohu8.com/highlight/detail?id=2551240539","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551240539?lang=zh_cn&edition=full","pubTime":"2025-07-14 09:30","pubTimestamp":1752456611,"startTime":"0","endTime":"0","summary":"07月14日,康辰药业股价大幅上涨,截至09点30分,康辰药业上涨5.06%,报46.13元/股,创近4年新高,成交2447万元,换手率0.34%,振幅2.57%。主营业务及业绩康辰药业公司主营业务为以创新药研发为核心、以临床需求为导向,集研发、生产和销售于一体。最新财报显示,今年一季报,康辰药业实现营业收入2.12亿元,同比增长6.41%,净利润为4,449.74万元,同比增长6.83%,基本每股收益为0.28元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071409312695416b26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071409312695416b26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603590","BK0239"],"gpt_icon":0},{"id":"2551731915","title":"每周股票复盘:康辰药业(603590)股票连续三日涨幅偏离值累计超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551731915","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551731915?lang=zh_cn&edition=full","pubTime":"2025-07-13 01:37","pubTimestamp":1752341827,"startTime":"0","endTime":"0","summary":"截至2025年7月11日收盘,康辰药业报收于43.91元,较上周的34.5元上涨27.28%。本周,康辰药业7月11日盘中最高价报44.75元,股价触及近一年最高点。公司公告汇总康辰药业发布股票交易异常波动公告,指出公司股票于2025年7月9日、7月10日、7月11日连续3个交易日收盘价格涨幅偏离值累计超过20%,属于股票交易异常波动情形。此外,公司全资子公司康辰药业(香港)有限公司持有Nuance Biotech 4.96%股权。2025年7月9日,Merck宣布收购Verona Pharma,总交易价值约为100亿美元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071300000159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603590"],"gpt_icon":0},{"id":"2550930548","title":"康辰药业最新公告:全资子公司康辰药业(香港)有限公司持有Nuance Biotech 4.96%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2550930548","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550930548?lang=zh_cn&edition=full","pubTime":"2025-07-11 19:09","pubTimestamp":1752232195,"startTime":"0","endTime":"0","summary":"康辰药业公告称,公司股票于2025年7月9日、7月10日、7月11日连续3个交易日收盘价格涨幅偏离值累计超过20%,属于股票交易异常波动情形。2021年6月,Nuance Biotech下属子公司与VeronaPharma签署协议,被授予在大中华区临床开发与商业化“恩司芬群”的独家权利。2025年7月9日,Merck官网宣布收购VeronaPharma,总交易价值约为100亿美元。公司的全资子公司康辰药业(香港)有限公司系NuanceBiotech的股东,截至目前持有其4.96%股权。公司如有与NuanceBiotech进一步合作的事项,将及时进行披露。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071100034223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603590","BK0239"],"gpt_icon":0},{"id":"2550936966","title":"7月11日康辰药业(603590)龙虎榜数据:机构净买入3167.54万元(3日)","url":"https://stock-news.laohu8.com/highlight/detail?id=2550936966","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550936966?lang=zh_cn&edition=full","pubTime":"2025-07-11 17:22","pubTimestamp":1752225774,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2025年7月11日公布的交易公开信息显示,康辰药业因非ST、*ST和S证券连续三个交易日内收盘价格涨幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年7月11日收盘,康辰药业报收于43.91元,上涨7.94%,换手率10.37%,成交量16.3万手,成交额7.15亿元。从龙虎榜公布的三日买卖数据来看,机构合计净买入3167.54万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071100028764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603590"],"gpt_icon":0},{"id":"2550615911","title":"7月10日康辰药业(603590)涨停分析:创新药突破、营销转型、高分红驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2550615911","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550615911?lang=zh_cn&edition=full","pubTime":"2025-07-10 15:21","pubTimestamp":1752132097,"startTime":"0","endTime":"0","summary":"证券之星消息,康辰药业7月10日涨停收盘,收盘价40.68元。该股于9点30分涨停,6次打开涨停,截止收盘封单资金为5696.27万元,占其流通市值0.89%。7月10日的资金流向数据方面,主力资金净流入2231.43万元,占总成交额7.62%,游资资金净流出1538.11万元,占总成交额5.26%,散户资金净流出693.32万元,占总成交额2.37%。近5日资金流向一览见下表:该股为创新药,医药,创投概念热股,当日创新药概念上涨1.16%,医药概念上涨1.11%,创投概念上涨0.85%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071000018650.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603590","BK1161","BK1574","BK0239","06978","159992"],"gpt_icon":0},{"id":"2550660707","title":"【创新药概念股反复活跃,塞力医疗、康辰药业触及涨停】创新药概念股反复活跃,塞力医疗、康辰药业触及涨停,海思科涨超7%,先达股份、华纳药厂、微芯生物纷纷上涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2550660707","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550660707?lang=zh_cn&edition=full","pubTime":"2025-07-10 09:46","pubTimestamp":1752111976,"startTime":"0","endTime":"0","summary":"创新药概念股反复活跃,塞力医疗、康辰药业触及涨停,海思科涨超7%,先达股份、华纳药厂、微芯生物纷纷上涨。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f4ae4484572f275cf3aa38bb605c2821","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/10094651600059.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0077","BK1161","BK0229","BK0250","688321","BK0033","603590","603086","BK0188","002653","BK0028","BK1574","688799","BK0239","159992","603716","06978"],"gpt_icon":0},{"id":"2550502314","title":"异动快报:康辰药业(603590)7月9日13点13分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2550502314","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550502314?lang=zh_cn&edition=full","pubTime":"2025-07-09 13:15","pubTimestamp":1752038127,"startTime":"0","endTime":"0","summary":"证券之星7月9日盘中消息,13点13分康辰药业触及涨停板。目前价格38.17,上涨10.0%。其所属行业生物制品目前下跌。领涨股为奥浦迈。该股为创投,猴痘概念,创新药概念热股,当日创投概念上涨0.29%,猴痘概念概念上涨0.13%,创新药概念上涨0.06%。7月9日的资金流向数据方面,主力资金净流入121.26万元,占总成交额2.67%,游资资金净流入94.02万元,占总成交额2.07%,散户资金净流出215.28万元,占总成交额4.74%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070900018238.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603590"],"gpt_icon":0},{"id":"2550502517","title":"康辰药业涨5.33% 创新药政策落地引发资金博弈","url":"https://stock-news.laohu8.com/highlight/detail?id=2550502517","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550502517?lang=zh_cn&edition=full","pubTime":"2025-07-09 13:06","pubTimestamp":1752037590,"startTime":"0","endTime":"0","summary":"康辰药业股价今日大幅上涨,截至13点05分,最新价报36.55元/股,涨幅达5.33%。资金博弈与政策预期共振康辰药业近期股价波动与主力资金流向密切相关。创新药政策落地后,部分资金选择兑现收益,叠加生物制品板块内部分化,加剧调仓需求。此外,公司动态市盈率从6月底的28.15倍升至7月9日的129.33倍,估值性价比边际下降引发资金向低估值标的迁移。产品迭代与研发转化定调价值中枢康辰药业长期估值取决于核心单品依赖症的破解进展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709130636a43f8012&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709130636a43f8012&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","159992","603590"],"gpt_icon":0},{"id":"2549370468","title":"康辰药业涨5.8% 券商看好","url":"https://stock-news.laohu8.com/highlight/detail?id=2549370468","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549370468?lang=zh_cn&edition=full","pubTime":"2025-07-07 09:30","pubTimestamp":1751851831,"startTime":"0","endTime":"0","summary":"07月07日,康辰药业股价大幅上涨,截至09点30分,康辰药业上涨5.80%,报36.50元/股,创近1年新高,成交453万元,换手率0.08%,振幅5.80%。资金动向截止发稿,康辰药业获得主力净流入174万元,其中超大单流入55万元,大单流入118万元。最新财报显示,今年一季报,康辰药业实现营业收入2.12亿元,同比增长6.41%,净利润为4,449.74万元,同比增长6.83%,基本每股收益为0.28元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707093227979c6dcb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707093227979c6dcb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603590","BK0239"],"gpt_icon":0},{"id":"2549654342","title":"每周股票复盘:康辰药业(603590)KC1086获临床试验许可,赎回2000万现金管理产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2549654342","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549654342?lang=zh_cn&edition=full","pubTime":"2025-07-06 03:00","pubTimestamp":1751742034,"startTime":"0","endTime":"0","summary":"截至2025年7月4日收盘,康辰药业报收于34.5元,较上周的31.58元上涨9.25%。本周,康辰药业7月4日盘中最高价报34.54元。公司公告汇总:康辰药业赎回2000万元本金保障浮动收益型现金管理产品,收益30.04万元。康辰药业关于KC1086项目获得临床试验通知书的公告显示,公司收到国家药品监督管理局核准签发的化学药品1类创新药KC1086片的临床试验通知书,拟用于晚期复发或转移性实体瘤的治疗。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070600000326.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK0239","BK1141","03347","603590","BK1583"],"gpt_icon":0},{"id":"2548822018","title":"康辰药业涨5.13% 创新药管线价值重估预期升温","url":"https://stock-news.laohu8.com/highlight/detail?id=2548822018","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548822018?lang=zh_cn&edition=full","pubTime":"2025-07-03 14:13","pubTimestamp":1751523233,"startTime":"0","endTime":"0","summary":"康辰药业股价今日大幅上涨,截至14点13分,最新价为33.63元/股,涨幅达5.13%。资金博弈与估值调整共振康辰药业近期股价波动与主力资金流向密切相关。创新药管线价值重估机遇公司长期价值锚定于创新药研发进展及产品梯队建设。机构关注点聚焦研发投入强度,若二季度研发费用率持续提升,可能激活市场对管线价值的重估预期。但需注意2024年净利润同比骤降71.8%反映的产品周期风险,后续需验证新药商业化能力能否支撑当前估值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703141354a72c0490&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703141354a72c0490&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603590","159992"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752878210075,"stockEarnings":[{"period":"1week","weight":0.2469},{"period":"1month","weight":0.7724},{"period":"3month","weight":0.9634},{"period":"6month","weight":1.4439},{"period":"1year","weight":1.2362},{"period":"ytd","weight":1.3732}],"compareEarnings":[{"period":"1week","weight":0.0069},{"period":"1month","weight":0.043},{"period":"3month","weight":0.0787},{"period":"6month","weight":0.0903},{"period":"1year","weight":0.1872},{"period":"ytd","weight":0.0545}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京康辰药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"11180人(较上一季度减少2.60%)","perCapita":"14064股","listingDate":"2018-08-27","address":"北京市密云区经济开发区兴盛南路11号","registeredCapital":"15935万元","survey":" 北京康辰药业股份有限公司的主营业务是医药制造业,从事化学药品制剂制造。公司的主要产品是注射用尖吻蝮蛇血凝酶、鲑降钙素注射液、鲑降钙素鼻用喷雾剂。公司被授予“中国医药创新企业100强”、“中国化药企业TOP100排行榜”、“北京制造业企业百强”、“北京高精尖企业百强”、“北京专精特新企业百强”、“北京市就业创业工作先进集体”、“北京市密云区统计诚信示范企业”,以及“2024年度中药创新十大贡献企业金手杖奖”等荣誉资质,企业实力再获认可。","listedPrice":24.34},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康辰药业(603590)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康辰药业(603590)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康辰药业,603590,康辰药业股票,康辰药业股票老虎,康辰药业股票老虎国际,康辰药业行情,康辰药业股票行情,康辰药业股价,康辰药业股市,康辰药业股票价格,康辰药业股票交易,康辰药业股票购买,康辰药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康辰药业(603590)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康辰药业(603590)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}